The HIV protease inhibitor, nelfinavir, primarily used for the treatment of HIV infections, has later been shown to be effective in various infectious diseases including malaria. Nelfinavir may trigger mitochondria-independent cell death. Erythrocytes may undergo eryptosis, a mitochondria-independent suicidal cell death characterized by cell shrinkage and phosphatidylserine translocation to the erythrocyte surface. Triggers of eryptosis include oxidative stress and increase of cytosolic Ca 2+ -activity ([Ca 2+ ]i). During malaria, accelerated death of infected erythrocytes may decrease parasitemia and thus favorably influence the clinical course of the disease. In the present study, phosphatidylserine abundance at the cell surface was estimated from annexin V binding, cell volume from forward scatter, reactive oxidant species (ROS) from 2',7'-dichlorodihydrofluorescein diacetate (DCFDA) fluorescence, and [Ca 2+ ]i from Fluo3-fluorescence. A 48 h treatment of human erythrocytes with nelfinavir significantly increased the percentage of annexin-V-binding cells (≥5µg/mL), significantly decreased forward scatter (≥2.5µg/mL), significantly increased ROS abundance (10 µg/mL), and significantly increased [Ca 2+ ]i (≥5 µg/mL). The up-regulation of annexin-V-binding following nelfinavir treatment was significantly blunted, but not abolished by either addition of the antioxidant N-acetylcysteine (1 mM) or removal of extracellular Ca 2+ . In conclusion, exposure of erythrocytes to nelfinavir induces oxidative stress and Ca 2+ entry, thus leading to suicidal erythrocyte death characterized by erythrocyte shrinkage and erythrocyte membrane scrambling.
Introduction
Nelfinavir, a specific HIV protease inhibitor, has originally been developed for the treatment of HIV infections and subsequently been shown to be effective in further infectious diseases including SARS, tuberculosis, and malaria [1] [2] [3] [4] [5] . Beyond that, nelfinavir may trigger death of tumor cells and thus counteracts malignancy [2, 3, 6, 7] . Nelfinavir is in part effective by triggering of mitochondria-independent apoptosis [2, 3] .
In analogy to apoptosis of nucleated cells, erythrocytes could enter eryptosis, a suicidal death characterized by cell shrinkage [8] and translocation of phosphatidylserine from the cell interior to the erythrocyte surface [9] . Cellular mechanisms involved in the stimulation of eryptosis include oxidative stress [9] , increased cytosolic Ca 2+ activity ([Ca 2+ ]i), ceramide [10] , energy depletion [9] , and activated caspases [9, 11, 12] . Moreover, eryptosis may be stimulated by casein kinase 1α, Janus-activated kinase JAK3, protein kinase C, p38 kinase, and PAK2 kinase [9] . Eryptosis is inhibited by AMP activated kinase AMPK, cGMP-dependent protein kinase, sorafenib and sunitinib sensitive kinases [9] . Eryptosis is distinct from programmed erythrocyte necrosis [13] , which is triggered by pore-forming bacterial toxins.
Eryptosis is stimulated by diverse xenobiotics [9, . Eryptosis is further triggered during malaria and accelerated eryptosis favourably influences the clinical course of the disease [51] .
The present study explored, whether and how nelfinavir stimulates eryptosis. To this end, erythrocytes from healthy volunteers were exposed to nelfinavir and phosphatidylserine abundance at the erythrocyte surface, cell volume, abundance of reactive oxidant species and [Ca 2+ ]i determined utilizing flow cytometry.
Results
The present study explored whether nelfinavir is capable to trigger eryptosis, the suicidal erythrocyte death. Hallmarks of eryptosis are cell shrinkage and phospholipid scrambling of the cell membrane with phosphatidylserine translocation to the cell surface. In order to quantify phospholipid scrambling of the cell membrane, phosphatidylserine abundance at the cell surface was quantified by determination of phosphatidylserine-binding FITC-labelled annexin-V in flow cytometry. As shown in Figure 1 , a 48 h exposure to nelfinavir increased the percentage of annexin-V-binding erythrocytes, an effect reaching statistical significance at 5 μg/mL nelfinavir concentration. Hemoglobin concentration in the supernatant was determined in order to estimate the effect of nelfinavir on hemolysis. According to hemoglobin concentration in the supernatant, a 48 h incubation with 0, 2.5, 5 and 10 μg/mL Nelfinavir resulted in hemolysis of 1.9% ± 0.3%, 3.5% ± 0.3%. 4.0% ± 0.2% and 7.0% ± 1.0% (n = 5), respectively.
Erythrocyte cell volume was estimated from forward scatter in flow cytometry. As illustrated in Figure 2 , a 48 h nelfinavir treatment was followed by a decrease of erythrocyte forward scatter, an effect reaching statistical significance at 2.5 µg/mL nelfinavir concentration. Mechanisms stimulating eryptosis include oxidative stress. Thus, additional experiments explored, whether nelfinavir influences the formation of reactive oxygen species (ROS). To this end, ROS was quantified utilizing 2',7'-dichlorodihydrofluorescein diacetate (DCFDA). As illustrated in Figure 3A ,B, a 48 h exposure to nelfinavir (10 µg/mL) was followed by a significant increase of DCFDA fluorescence. Nelfinavir thus induced oxidative stress. An additional series of experiments explored whether nelfinavir-induced translocation of phosphatidylserine to the cell surface required oxidative stress and could thus be abrogated by the reducing substance N-acetylcysteine. To this end, erythrocytes were incubated for 48 h in the absence or presence of 10 µg/mL nelfinavir, both in the absence or presence of N-acetylcysteine (1 mM). As shown in Figure 3C , addition of N-acetylcysteine (1 mM) significantly blunted the effect of nelfinavir on annexin-V-binding, an observation indicating that oxidative stress contributed to the stimulation of cell membrane scrambling by nelfinavir. However, even in the presence of N-acetylcysteine nelfinavir significantly increased the percentage of annexin-V-binding erythrocytes, indicating that eryptosis was in part due to mechanisms other than oxidative stress. 
Discussion
The present observations reveal a novel effect of nelfinavir, i.e., the triggering of eryptosis, the suicidal erythrocyte death characterized by cell shrinkage and erythrocyte cell membrane scrambling with phosphatidylserine translocation from the cell interior to the erythrocyte surface. The nelfinavir concentration required for stimulation of erythrocyte cell membrane scrambling (5 µg/mL) was similar to plasma concentrations (10 µg/mL) reported in vivo [52] . It must be kept in mind, though, that 98% of nelfinavir is bound to plasma proteins [53] and that the free nelfinavir concentration may be accordingly lower [52] . How binding to erythrocytes competes with binding to plasma proteins, is, however, not known. ]i was presumably in part the result of oxidative stress, which activates oxidant sensitive Ca 2+ permeable erythrocytic cation channels [9] . Beyond that, oxidative stress may trigger eryptosis by further, rather illdefined mechanisms. Nelfinavir has similarly been reported to induce oxidative stress in nucleated cells [2, 3, [54] [55] [56] [57] [58] .
Eryptosis serves to clear defective erythrocytes prior to hemolysis with release of hemoglobin, which may undergo glomerular filtration in the kidney and precipitate in the acidic lumen of renal tubules thus occluding affected nephrons [59] . Eryptosis further serves to remove infected erythrocytes during malaria [51] . The malaria pathogen Plasmodium imposes oxidative stress on the host erythrocyte leading to activation of several host cell ion channels including Ca 2+ -permeable erythrocyte cation channels [9, 60] . The subsequent Ca 2+ entry triggers cell membrane scrambling, phosphatidylserine translocation, binding to phosphatidylserine receptors at phagocytes, phagocytosis and thus removal of the infected erythrocytes from circulating blood [51] . Eryptotic removal of infected erythrocytes reduces parasitemia and thus favorably influences the clinical course of malaria. Enhanced susceptibility to eryptosis presumably confers protection against a severe course of malaria in several genetic erythrocyte disorders, such as sickle-cell trait, beta-thalassemia-trait, homozygous Hb-C and homozygous G6PD-deficiency [9, [61] [62] [63] . Accelerated eryptosis further contributes to the protective effect against malaria of iron deficiency [64] , lead intoxication [64] , treatment with chlorpromazine [65] or presence of NO synthase inhibitors [65] . It is tempting to speculate that induction of eryptosis contributes to the antimalarial effect of nelfinavir. As infected erythrocytes are exposed to oxidative stress [51] , they are particularly sensitive to triggers of eryptosis and may thus specifically be eleimninated by eryptosis inducing substances. Clearly, additional experimentation is required to confirm or falsify this speculation.
As phosphatidylserine exposing erythrocytes are engulfed by macrophages and thus rapidly cleared from circulating blood, excessive eryptosis may lead to anemia [9] . Moreover, phosphatidylserine exposing erythrocytes may bind to endothelial cells of the vascular wall [66] , trigger blood clotting and induce thrombosis [67] [68] [69] . Phosphatidylserine exposing erythrocytes thus may compromise microcirculation [10, 67, [70] [71] [72] [73] .
Experimental Section

Erythrocytes, Solutions and Chemicals
Fresh Lithium-Heparin-anticoagulated blood samples were kindly provided by the blood bank of the University of Tübingen. The study is approved by the ethics committee of the University of Tübingen (184/2003 V). The blood was centrifuged at 120 g for 20 min at 23 °C and the platelets and leukocytes-containing supernatant was disposed. Erythrocytes were incubated in vitro for 48 h at a hematocrit of 0.4% in Ringer solution containing (in mM) 125 NaCl, 5 KCl, 1 MgSO4, 32 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES), 5 glucose, and 1 CaCl2; the pH was adjusted to 7.4 and the temperature kept at 37 °C. Where indicated, erythrocytes were exposed to nelfinavir (Sigma Aldrich, Hamburg, Germany), which was dissolved in DMSO (Carl Roth, Karlsruhe, Germany). For comparison, the effect of 1 µL DMSO/mL Ringer was tested. was too short to trigger significant phosphatidylserine translocation.
Annexin-V-Binding and Forward Scatter
Reactive Oxidant Species (ROS)
Oxidative stress was determined utilizing 2',7'-dichlorodihydrofluorescein diacetate (DCFDA). After incubation, a 150 µL suspension of erythrocytes was washed in Ringer solution and then stained with DCFDA (Sigma, Schnelldorf, Germany) in Ringer solution containing DCFDA at a final concentration of 10 µM. Erythrocytes were incubated at 37 °C for 30 min in the dark and then washed three times in Ringer solution. The DCFDA-loaded erythrocytes were resuspended in 200 µL Ringer solution, and ROS-dependent fluorescence intensity was measured at an excitation wavelength of 488 nm and an emission wavelength of 530 nm on a FACS Calibur (BD). 
Intracellular Ca
Hemolysis
For the determination of hemolysis, the samples were centrifuged (3 min at 1600 rpm, room temperature) after incubation under the respective experimental conditions and the supernatants were harvested. As a measure of hemolysis, the hemoglobin (Hb) concentration of the supernatant was determined photometrically at 405 nm. The absorption of the supernatant of erythrocytes lysed in distilled water was defined as 100% hemolysis. Hemolysis is expressed in % of total hemolysis.
Statistics
Data are expressed as arithmetic means ± SEM. As indicated in the figure legends, statistical analysis was made using ANOVA with Tukey's test as post-test and t test as appropriate. n denotes the number of different erythrocyte specimens studied. Since different erythrocyte specimens used in distinct experiments are differently susceptible to triggers of eryptosis, the same erythrocyte specimens have been used for control and experimental conditions.
Conclusions
Nelfinavir stimulates eryptosis, the suicidal erythrocyte death characterized by erythrocyte cell membrane scrambling and cell shrinkage. The effect is paralleled by, and at least partially due to, oxidative stress and increase of cytosolic Ca 2+ activity.
